Disclosed herein are hydridoma cell lines producing monoclonal human natural IgM antibodies and methods of use thereof. The antibodies are the monoclonal equivalents of circulating human natural antibodies. Also disclosed herein are pharmaceutical formulations and methods for treating HIV-1 infected individuals using the monoclonal human natural antibodies.

São divulgadas nisto as linhas da pilha do hydridoma produzindo antibodies naturais humanos monoclonal de IgM e métodos do uso disso. Os antibodies são os equivalentes monoclonal de circular antibodies naturais humanos. São divulgados também nisto os formulations e os métodos pharmaceutical para tratar indivíduos infected HIV-1 usando os antibodies naturais humanos monoclonal.